Groove Botanicals(GRVE)
$0.01+0.00 (+19.80%)
GRVE
Groove Botanicals financials statements
$0.01
At close:+0.00 (+19.80%)
Groove Botanicals (GRVE) Ratios
6 Followers
Groove Botanicals Ratios
GRVE's free cash flow for Q2 2027 was $-36.45K. For the 2027 fiscal year, GRVE's free cash flow was increased by $0.00 and operating cash flow was $-36.45K. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.00 | 0.00 | 0.00 | 0.01 | 0.10 |
| Quick Ratio | 0.00 | 0.00 | 0.00 | 0.01 | 0.10 |
| Cash Ratio | 0.00 | 0.00 | 0.00 | 0.01 | 0.10 |
| Solvency Ratio | -0.10 | -0.31 | -0.26 | 0.08 | 0.25 |
| Operating Cash Flow Ratio | -0.06 | -0.10 | -0.11 | -0.26 | -0.14 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | -1.28 | -0.44 |
| Net Current Asset Value | $ -1.47M | $ -1.11M | $ -760.56K | $ -438.30K | $ -454.94K |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.00 | 17.83 | 3.38 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.00 | -0.21 | -0.36 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | -0.26 | -0.57 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | -0.00 | -0.00 | -0.00 | -0.01 | -0.11 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | -39.49 | -0.13 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | -39.49 | -1.82 | -2.07 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.02 | 0.06 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Net Debt to EBITDA | 0.01 | 0.00 | 0.01 | -3.53 | 0.00 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 100.00% | 100.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | -14874.07% | -5171.92% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | -2049.83% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | -14873.73% | -5061.72% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | -10231.02% | -3607.28% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | -10231.02% | -3607.28% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | -10231.02% | -3607.28% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 100.00% | 266.98% | 75.81% | 68.79% | 71.27% |
| Return on Assets (ROA) | -3156.97% | -7727.96% | -9434.59% | -2391.56% | -595.38% |
| Return on Equity (ROE) | 9.53% | 31.47% | 26.57% | 27.54% | 63.85% |
| Return on Capital Employed (ROCE) | 9.53% | 11.79% | 35.05% | 40.04% | 89.59% |
| Return on Invested Capital (ROIC) | 9.53% | 11.79% | 35.05% | 50.39% | 140.46% |
| Return on Tangible Assets | -3156.97% | -7727.96% | -9434.59% | -2391.56% | -595.38% |
| Earnings Yield | -23.94% | -98.87% | -6.86% | -2.51% | -11.30% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 32.08 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.23 | 0.17 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | -0.00 | -0.02 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 11.38 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 11.38 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 11.38 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Free Cash Flow Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Dividend Paid and CapEx Coverage Ratio | -0.42 | 0.00 | 0.00 | -38467.67 | -14581.00 |
| Capital Expenditure Coverage Ratio | 0.00 | 0.00 | 0.00 | -38467.67 | -14581.00 |
| Operating Cash Flow Coverage Ratio | 0.00 | 0.00 | 0.00 | -1.28 | -0.44 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | -97.80 | -9.05 |
| Free Cash Flow Yield | -15.68% | -30.41% | -2.95% | -2.40% | -2.84% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -1.63 | -0.60 | -14.57 | -39.89 | -8.85 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 4081.41 | 319.12 |
| Price-to-Book (P/B) Ratio | -0.40 | -0.32 | -3.87 | -10.99 | -5.65 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -6.38 | -3.29 | -33.90 | -41.73 | -35.24 |
| Price-to-Operating Cash Flow Ratio | -6.38 | -3.29 | -33.90 | -41.73 | -35.24 |
| Price-to-Earnings Growth (PEG) Ratio | 0.04 | -0.01 | -0.07 | 0.60 | 0.24 |
| Enterprise Value Multiple | -4.17 | 0.00 | -11.04 | -202.64 | 0.00 |
| Enterprise Value | 583.00K | 351.24K | 2.94M | 4.90M | 2.69M |
| EV to EBITDA | -4.17 | 0.00 | -11.04 | -202.64 | 0.00 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 4153.81 | 333.55 |
| EV to Free Cash Flow | -6.36 | -3.27 | -33.88 | -42.47 | -36.84 |
| EV to Operating Cash Flow | -6.36 | -3.27 | -33.88 | -42.47 | -36.84 |
| Tangible Book Value Per Share | -0.02 | -0.02 | -0.01 | -0.01 | -0.01 |
| Shareholders’ Equity Per Share | -0.02 | -0.02 | -0.01 | -0.01 | -0.01 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.00 | -0.01 | -0.00 | -0.00 | -0.01 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 2.67 | 0.76 | 0.69 | 0.70 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 148.74 | 35.97 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 19.00 |
| Income Quality | 0.66 | 0.82 | 0.43 | 0.96 | 0.25 |
Currency in USD

